New Publication Delivers Inside Track on Centers for Medicare and Medicaid Services Device Reimbursement Rates

'Device Reimbursement Report Will Help Manufacturers Profit From

Complex CMS Rules,' FDAnews Publisher Cynthia Carter Says

Feb 07, 2002, 00:00 ET from FDAnews

    FALLS CHURCH, Va., Feb. 7 /PRNewswire/ -- The leading provider of news and
 information on the U.S. Food and Drug Administration (FDA) today announced the
 launch of the only newsletter devoted to tracking and explaining rules,
 regulations, pending legislation and other issues affecting Medicare and
 Medicaid reimbursement for medical devices.
     The new biweekly newsletter, Device Reimbursement Report, gives medical
 device makers, hospital administrators, lobbyists and other decisionmakers
 advance news and analysis of federal legislation affecting Medicare and
 reimbursement issues; up-to-date information on actions, rulings and
 timetables coming out of the Centers for Medicare and Medicaid Services (CMS);
 and inside looks at lobbying efforts of interested parties.
     "Device Reimbursement Report satisfies a major information need among
 buyers, users and manufacturers of medical devices," said Cynthia Carter,
 publisher of FDAnews. "More than ever before, providers need to know which
 devices will get higher reimbursement rates, which ones will be reclassified
 with lower rates and how different settings and uses can affect those rates of
 reimbursement -- and ultimately their bottom lines."
     On Nov. 29, 2001, the CMS released new rules for hospital Outpatient
 Prospective Payment Systems (OPPS), shifting to new methods of reimbursement
 for more than 1,100 high-tech medical procedures.
     "Reimbursement reform is one of the most far-reaching issues affecting
 medical devices today," said Richard Crider, editor of Device Reimbursement
 Report. "Advance warning of what CMS will reimburse -- and what it will not --
 will be the key to profits for both healthcare institutions and manufacturers
 in the months and years to come."
     Device Reimbursement Report also tracks changes and updates in Ambulatory
 Payment Classifications (APCs), as well as APC applications and appeals for
 reclassification; and provides its readers with essential details gleaned from
 Federal Register notices and CMS memoranda.
     Device Reimbursement Report, published 24 times a year, is available in
 print and electronic formats for $827/year.
     FDAnews is the premier provider of domestic and international regulatory,
 legislative and business news and information for executives in industries
 regulated by the U.S. Food and Drug Administration and the European
 Commission.  FDAnews also publishes Devices & Diagnostics Letter, The GMP
 Letter, Part 11 Compliance Report and many other information resources to help
 medical device and pharmaceutical executives meet their business and
 regulatory challenges.
     Since 1972, the seasoned staff of FDAnews journalists has been dedicated
 to providing executives in the regulated community with timely, insightful and
 practical news and analysis on mission critical issues, key industry
 developments and regulatory, legislative and policy initiatives.
     Pharmaceutical and medical device professionals rely on FDAnews' print and
 electronic newsletters, books, special reports, European documents and
 conferences to keep abreast of international standards, stay in compliance
 with the FDA's complex and ever-changing regulations, get their products to
 market faster and boost profits.
                     MAKE YOUR OPINION COUNT -  Click Here